present
studi
undertaken
determin
immun
respons
protect
efficaci
spike
protein
fragment
contain
neutral
epitop
turkey
coronaviru
tcov
prime
dna
vaccin
boost
recombin
protein
correspond
dna
vaccin
gene
segment
turkey
vaccin
prime
either
one
dose
two
dose
g
dna
vaccin
express
fragment
boost
one
dose
g
fragment
one
dose
g
dna
vaccin
mix
polyethyleneimin
pei
sodium
hyaluron
ha
follow
one
dose
g
dna
vaccin
one
dose
g
fragment
given
turkey
group
infecti
challeng
tcov
clinic
sign
tcov
detect
immunofluoresc
antibodi
ifa
assay
observ
less
number
turkey
vaccin
group
challeng
control
group
tcov
viral
rna
load
measur
quantit
realtim
revers
transcriptionpcr
lower
vaccin
turkey
challeng
control
turkey
turkey
produc
highest
level
tcov
proteinspecif
antibodi
viru
neutral
vn
titer
compar
turkey
significantli
less
tcov
detect
ifa
turkey
receiv
extra
dose
g
dna
mix
pei
ha
result
indic
dnaprim
proteinboost
dna
vaccin
regimen
target
tcov
fragment
encompass
neutral
epitop
induc
humor
immun
respons
partial
protect
turkey
infecti
challeng
tcov
turkey
coronaviru
tcov
member
famili
coronavirida
order
nidoviral
caus
atroph
enter
infect
turkey
lead
poor
feed
convers
uneven
bodi
weight
gain
signific
econom
loss
turkey
industri
unit
state
canada
dea
et
al
gomaa
et
al
europ
cavanagh
et
al
maurel
et
al
brazil
teixeira
et
al
clinic
sign
tcov
infect
includ
wateri
diarrhea
depress
ruffl
feather
decreas
consumpt
food
water
distend
intestin
gaseou
wateri
content
strike
gross
lesion
major
histopatholog
chang
blunt
villi
increas
crypt
depth
increas
width
villi
guy
gomaa
et
al
current
effect
vaccin
avail
control
tcov
infect
tcov
envelop
viru
liner
positivesens
singlestrand
rna
genom
size
kilobas
kb
spike
envelop
e
membran
nucleocapsid
n
protein
four
major
structur
protein
tcov
cao
et
al
aminotermin
subunit
protein
form
globular
head
spike
structur
surfac
coronavirus
contain
receptor
bind
domain
neutral
epitop
determin
host
tropism
humor
immun
godet
et
al
taguchi
kubo
et
al
ho
et
al
lu
et
al
zhou
et
al
chen
et
al
carboxylterminu
subunit
protein
construct
stalk
spike
structur
consist
transmembran
domain
fusion
peptid
induc
cell
fusion
viral
assembl
spiga
et
al
broer
et
al
howard
et
al
immun
coronavir
proteinbas
vaccin
produc
protect
neutral
antibodi
prevent
infect
challeng
johnson
et
al
zeng
et
al
du
et
al
shil
et
al
dna
vaccin
plasmid
dna
encod
protein
pathogen
interest
control
eukaryot
cell
promot
demonstr
induc
humor
cellular
immun
respons
laddi
weiner
sever
approach
also
investig
improv
low
immunogen
dna
vaccin
barouch
includ
coadministr
gene
encod
immunostimulatori
molecul
like
tang
et
al
cytosinephosphateguanin
cpg
motif
kinman
et
al
granulocytemacrophag
stimul
factor
gmcsf
tan
et
al
enhanc
immun
respons
approach
improv
immunogen
dna
vaccin
includ
target
dna
toward
proper
antigen
present
cell
like
dendrit
cell
kurzler
weiner
nchinda
et
al
appli
primeboost
strategi
prime
dna
boost
viral
vector
encod
antigen
protein
woo
et
al
wang
et
al
improv
dna
deliveri
electropor
incorpor
nanoparticl
increas
amount
stabil
dna
insid
transfect
cell
thu
enhanc
protein
express
level
transfect
dna
otten
et
al
van
drunen
littlevan
den
hunk
hannaman
nanoparticl
made
cation
lipid
polym
protect
dna
deliv
dna
target
cell
polyethyleneimin
pei
wide
use
polym
size
dnapei
complex
suitabl
endocyt
uptak
nonphagocyt
cell
jeong
et
al
insid
cell
pei
absorb
proton
ion
endosom
acidif
lead
osmot
ruptur
endosom
dna
releas
enter
nucleu
transfect
cell
boussif
et
al
addit
polysaccharidebas
polyanion
like
hyaluron
ha
improv
gene
transfect
effici
dnapei
complex
loosen
complex
access
gene
transcript
machineri
ito
et
al
polyc
disulfid
linkag
could
degrad
reduct
intracellular
environ
releas
dna
easili
achiev
higher
gene
express
uncleav
counterpart
neu
et
al
appli
advantag
exert
ha
disulfid
linkag
ternari
complex
dph
complex
consist
dna
disulfidecrosslink
low
molecular
linear
polyethyleneimin
clpei
sodium
hyaluron
prove
enhanc
transfect
effici
significantli
xu
et
al
fragment
tcov
protein
encompass
amino
acid
residu
shown
contain
neutral
epitop
previou
studi
chen
et
al
determin
whether
fragment
tcov
protein
could
stimul
protect
neutral
antibodi
respons
dna
vaccin
encod
fragment
gene
ternari
complex
compos
clpei
ha
recombin
fragment
protein
gener
thu
purpos
present
studi
determin
immun
respons
protect
efficaci
dna
vaccin
infecti
challeng
primeboost
strategi
prime
nake
dna
pei
nanoparticl
boost
recombin
fragment
protein
turkey
coronaviru
indiana
isol
tcov
propag
titrat
embryon
turkey
egg
previous
describ
loa
et
al
briefli
intestin
harvest
embryon
egg
inocul
tcov
homogen
serv
viru
stock
titrat
challeng
turkey
determin
median
embryo
infecti
dose
eid
viru
stock
tcov
serial
dilut
viru
stock
inocul
five
embryon
turkey
egg
per
dilut
day
inocul
embryon
intestin
harvest
subject
immunofluoresc
antibodi
ifa
assay
antiserum
tcov
determin
dose
infect
embryo
method
reed
muench
thayer
beard
turkey
egg
onedayold
turkey
poult
obtain
perdu
farm
thorntown
indiana
usa
turkey
egg
incub
incub
c
humid
level
jamesway
indian
trail
nc
usa
turkey
poult
hous
isol
floor
pen
feed
water
provid
ad
libitum
sera
collect
onedayold
turkey
poult
neg
tcovspecif
ab
protocol
care
use
turkey
egg
turkey
poult
present
studi
approv
purdu
univers
anim
care
use
committe
construct
dna
vaccin
encod
tcov
spike
protein
fragment
gene
encod
amino
acid
residu
protein
tcov
genbank
access
number
amplifi
primer
clone
ncoi
kpni
site
express
vector
novagen
madison
wi
usa
frame
upstream
seri
histidin
residu
construct
plasmid
purifi
qiafilt
tm
plasmid
giga
kit
qiagen
valencia
ca
usa
lysogeni
broth
lb
cultur
escherichia
coli
e
coli
strain
transform
express
tcov
fragment
purifi
plasmid
verifi
ifa
turkey
antitcov
serum
cell
transfect
use
fugen
hd
transfect
reagent
roch
indianapoli
usa
ratio
reagent
l
dna
g
accord
procedur
describ
previou
studi
chen
et
al
disulfidecrosslink
polyethyleneimin
provid
dr
yoon
yeo
format
dnaclpeiha
dph
complex
prepar
dr
peisheng
xu
solut
dna
gl
clpei
gl
acid
buffer
salin
hepe
mm
ph
mix
vv
incub
room
temperatur
min
prepar
complex
dna
clpei
dp
first
sequenti
dp
complex
ad
ha
solut
hepe
buffer
salin
hadna
ratio
ww
incub
room
temperatur
min
dph
complex
frozen
liquid
nitrogen
lyophil
complet
inocul
powder
dph
reconstitut
steril
water
concentr
gl
intramuscular
inject
express
tcov
fragment
purifi
plasmid
verifi
ifa
turkey
antitcov
serum
cell
transfect
g
dph
complex
consist
without
transfect
reagent
construct
transform
e
coli
strain
rosetta
express
tcov
fragment
harvest
purifi
accord
protocol
describ
previous
chen
et
al
size
kda
puriti
produc
tcov
fragment
confirm
sdspage
western
blot
analysi
onedayold
turkey
poult
use
two
trial
vaccin
challeng
experi
vaccin
schedul
summar
tabl
two
vaccin
trial
three
vaccin
trial
schedul
follow
viral
challeng
turkey
per
group
everi
turkey
group
sacrif
one
day
challeng
day
post
viral
inocul
dpi
dpi
trial
group
trial
group
trial
serv
neg
control
receiv
pb
instead
dna
vaccin
protein
viru
turkey
group
trial
group
trial
inject
intramuscularli
dna
plasmid
vector
pb
complet
freud
adjuv
cfa
sigmaaldrich
st
loui
mo
usa
vector
control
group
two
group
becam
challeng
control
group
oral
challeng
eid
tcov
respect
trial
turkey
prime
one
dose
g
day
boost
g
tcov
protein
cfa
day
viral
challeng
day
trial
dna
vaccin
given
day
tcov
protein
cfa
day
viral
challeng
day
turkey
receiv
one
dose
g
dph
complex
consist
dna
polym
clpei
ha
one
dose
g
one
dose
g
tcov
protein
cfa
viral
challeng
turkey
vaccin
intramuscularli
two
dose
g
one
dose
g
tcov
protein
cfa
viral
challeng
trial
clinic
sign
includ
depress
diarrhea
ruffl
feather
monitor
day
viral
challeng
turkey
poult
weight
evalu
statu
decreas
bodi
weight
gain
caus
tcov
infect
sera
collect
challeng
dpi
measur
tcovspecif
antibodi
respons
perform
tcov
fragmentbas
elisa
viru
neutral
vn
assay
one
day
challeng
dpi
turkey
poult
group
necropsi
variou
tissu
includ
thymu
spleen
ileum
jejunum
bursa
cecal
tonsil
collect
histopatholog
examin
ileum
jejunum
sampl
subject
ifa
assay
detect
tcov
antigen
ileum
sampl
use
determin
tcov
viral
rna
load
quantit
realtim
rtpcr
qrtpcr
spleen
sampl
process
determin
turkey
mrna
level
qrtpcr
long
segment
jejunum
adjac
merckel
diverticulum
long
segment
ileum
pair
ceca
collect
content
group
trial
turkey
receiv
two
dose
vaccin
neg
control
turkey
turkey
receiv
one
dose
g
vector
pb
turkey
inocul
one
dose
g
one
dose
g
tcov
spike
protein
pro
trial
three
dose
vaccin
given
neg
control
turkey
turkey
receiv
two
dose
g
vector
pb
turkey
prime
one
dose
g
dphcomplex
complex
dna
disulfidecrosslink
polyethyleneimin
clpei
sodium
hyaluron
ha
complex
one
dose
g
boost
g
pro
turkey
prime
dose
g
boost
g
pro
b
cfa
complet
freud
adjuv
c
effect
dose
infect
inocul
embryo
intestin
segment
collect
rins
away
use
cold
pb
intestin
segment
fold
wrap
sheet
aluminum
foil
frozen
c
frozen
specimen
trim
c
three
section
ileum
three
jejunum
per
sampl
prepar
ifa
antiserum
tcov
primari
ab
fitcconjug
goat
antiturkey
igg
h
l
ab
kpl
gaithersburg
md
usa
secondari
ab
use
stain
acetonefix
section
frozen
ileum
jejunum
sampl
section
observ
fluoresc
microscop
ifa
score
three
independ
field
per
section
determin
infect
tcov
turkey
determin
sum
ifa
score
present
three
categori
modifi
previou
studi
laboratori
loa
et
al
strength
posit
signal
scale
neg
weak
moder
strong
distribut
posit
cell
rang
neg
focal
multifoc
diffus
number
posit
cell
neg
low
medium
high
procedur
tcov
fragmentbas
elisa
vn
assay
describ
previous
chen
et
al
brief
serum
sampl
dilut
react
tcov
fragment
coat
plate
bound
antibodi
detect
horseradish
peroxidas
hrp
conjug
goat
antiturkey
igg
ab
dilut
optic
densiti
nm
od
nm
read
vmax
tm
elisa
micropl
reader
molecular
devic
sunnyval
ca
usa
vn
assay
sera
heatinactiv
c
min
fourfold
dilut
serial
dilut
serum
incub
eid
tcov
c
h
mixtur
subsequ
inocul
five
turkey
embryon
egg
via
amniot
sac
rout
per
dilut
serum
sampl
intestin
turkey
embryo
harvest
incub
three
day
examin
ifa
use
tcov
antiserum
dilut
serum
prevent
infect
tcov
inocul
egg
calcul
vn
titer
reed
muench
method
thayer
beard
total
rna
extract
spleen
rnalat
stabil
reagent
qiagen
valencia
ca
usa
use
rneasi
mini
kit
qiagen
valencia
ca
usa
extract
rna
treat
rnasefre
dnase
qiagen
valencia
ca
usa
remov
possibl
genom
dna
contamin
singl
strand
cdna
synthes
use
random
primer
superscript
iii
revers
transcriptas
invitrogen
san
diego
ca
usa
cdna
subject
sybr
greenbas
qrtpcr
forward
primer
tkifngf
revers
primer
tkifngr
specif
turkey
mrna
reaction
gadph
forward
primer
gadph
revers
primer
tcaaaggtggagg
target
gadph
mrna
use
intern
control
sybr
greenbas
qrtpcr
sybr
greenbas
qrtpcr
mixtur
contain
nm
forward
revers
primer
express
sybr
green
qpcr
univers
qpcr
supermix
invitrogen
carlsbad
ca
usa
use
paramet
thermal
cycl
min
c
min
c
cycl
c
acquir
sybr
green
signal
c
min
c
realtim
pcr
cycler
rotorq
qiagen
melt
curv
analysi
perform
c
c
ramp
speed
cs
result
melt
curv
analysi
use
evalu
specif
amplif
product
cycl
threshold
ct
valu
gene
normal
ct
valu
gadph
mrna
level
group
group
compar
group
mrna
level
group
group
group
compar
group
fold
chang
gene
express
calcul
ct
ct
ct
ct
gadph
ct
ct
group
averag
ct
correspond
neg
control
group
modif
previou
studi
chen
et
al
cdna
revers
transcrib
total
rna
collect
ileum
sampl
rnalat
stabil
reagent
subject
taqman
probebas
qrtpcr
primer
probe
specif
tcov
gene
cycl
profil
min
c
follow
cycl
c
c
min
acquir
fluoresc
fam
realtim
pcr
cycler
rotorq
qiagen
concentr
tcov
fgl
calcul
absolut
quantit
standard
curv
develop
dilut
plasmid
nucleotid
posit
start
codon
gene
tcov
known
concentr
measur
genequ
pro
rnadna
calcul
ge
healthcar
bioscienc
piscataway
nj
usa
ct
valu
sampl
larger
ct
valu
nontempl
control
ntc
larger
total
cycl
number
signal
threshold
concentr
tcov
sampl
consid
fgl
normal
data
evalu
quantilequantil
qq
plot
data
distribut
normal
nonparametr
mannwhitney
u
test
use
compar
data
two
group
kruskalw
h
test
use
analyz
data
three
group
normal
distribut
data
underw
independ
ttest
oneway
analysi
varianc
anova
statist
analys
use
spss
program
spss
inc
chicago
il
usa
statist
signific
set
p
green
fluoresc
seen
cytoplasm
cell
transfect
transfus
reagent
dph
complex
without
transfus
reagent
indic
express
tcov
fragment
cell
fig
purifi
tcov
fragment
detect
serum
collect
tcovinfect
turkey
western
blot
size
kda
fig
trial
bodi
weight
turkey
group
signific
differ
p
viral
challeng
tabl
challeng
tcov
turkey
react
serum
collect
tcovinfect
turkey
lane
nc
tcov
protein
react
serum
noninfect
turkey
lane
protein
marker
kda
lane
antitcov
tcov
protein
react
serum
tcovinfect
turkey
darker
band
kda
monom
tcov
protein
lighter
band
kda
dimer
tcov
protein
weigh
significantli
heavier
group
p
lighter
turkey
p
dpi
trial
trial
vaccin
turkey
heavier
nonvaccin
turkey
group
nc
dpi
howev
signific
differ
p
dna
vaccin
dnaprim
proteinboost
approach
target
tcov
fragment
contain
neutral
epitop
reduc
number
turkey
show
clinic
sign
decreas
intens
number
distribut
ifaposit
enterocyt
diminish
viral
load
ileum
tcovinfect
turkey
tabl
trial
turkey
show
less
clinic
sign
significantli
lower
ifa
score
p
unvaccin
turkey
dpi
viral
rna
load
determin
qrtpcr
also
lower
ileum
vaccin
turkey
unvaccin
turkey
although
statist
differ
p
probabl
due
sampl
variat
trial
ifa
score
viral
load
tabl
bodi
weight
vaccin
turkey
turkey
neg
vector
control
group
challeng
day
post
inocul
dpi
turkey
coronaviru
c
dpi
trial
three
group
label
differ
letter
averag
standard
deviat
signific
differ
anova
tukey
hsd
analysi
p
dpi
trial
three
group
label
differ
letter
averag
standard
deviat
signific
differ
anova
tukey
hsd
analysi
p
e
dpi
trial
three
group
label
differ
letter
averag
standard
deviat
signific
differ
anova
tukey
hsd
analysi
p
lower
turkey
nonvaccin
turkey
dpi
turkey
lower
viral
rna
load
ileum
unvaccin
turkey
turkey
also
significantli
lower
ifa
score
group
dpi
p
vaccin
tcov
fragment
contain
neutral
epitop
induc
signific
antibodi
respons
trial
fig
one
day
viral
challeng
turkey
turkey
turkey
level
antibodi
od
valu
significantli
increas
antibodi
level
p
detect
turkey
dpi
compar
challeng
trail
trial
level
antibodi
turkey
higher
challeng
statist
signific
p
level
antibodi
turkey
significantli
higher
p
found
unvaccin
turkey
challeng
one
dose
g
dna
vaccin
turkey
produc
significantli
higher
p
antibodi
viral
challeng
extra
dose
g
dna
vaccin
incorpor
pei
ha
turkey
elicit
higher
antibodi
challeng
although
signific
differ
found
p
trial
vaccin
turkey
respond
tcov
infect
much
faster
nonvaccin
turkey
significantli
increas
antibodi
level
detect
dpi
p
weak
moder
strong
distribut
posit
cell
neg
focal
multifoc
diffus
number
posit
cell
neg
low
medium
high
qrtpcr
quantit
realtim
rtpcr
use
measur
viral
load
tcov
gene
intestin
sampl
present
rang
tcov
concentr
fgl
follow
averag
standard
deviat
detect
turkey
group
time
point
signific
differ
found
group
kruskalw
h
analysi
p
e
differ
letter
indic
signific
differ
among
group
anova
tukey
hsd
analysi
p
f
differ
letter
indic
signific
differ
among
group
anova
tukey
hsd
analysi
p
g
differ
letter
indic
signific
differ
among
group
anova
tukey
hsd
analysi
p
significantli
higher
p
vn
antibodi
tcov
elicit
vaccin
turkey
challeng
tcov
fig
trial
serum
collect
vector
control
turkey
viral
challeng
could
neutral
tcov
infect
embryon
egg
vn
titer
serum
collect
nonvaccin
turkey
dpi
one
day
viral
challeng
vn
titer
detect
turkey
turkey
turkey
dpi
turkey
turkey
turkey
g
produc
vn
titer
dpi
vaccin
turkey
respond
infect
tcov
trial
vn
titer
detect
turkey
challeng
increas
significantli
dpi
p
declin
dpi
trial
turkey
higher
vn
titer
nonvaccin
turkey
challeng
turkey
faster
neutral
antibodi
respons
produc
significantli
higher
level
p
neutral
antibodi
dpi
turkey
produc
significantli
higher
level
p
neutral
antibodi
dpi
trial
transcript
gene
turkey
upregul
viral
challeng
dpi
dpi
fig
vector
control
turkey
lower
mrna
level
compar
turkey
challeng
show
similar
pattern
induct
viral
challeng
statist
signific
p
among
differ
concentr
produc
turkey
group
challeng
trial
transcript
gene
turkey
downregul
significantli
challeng
p
mrna
level
level
found
turkey
respect
fig
challeng
level
increas
significantli
turkey
p
turkey
higher
mrna
level
dpi
compar
level
detect
challeng
dpi
turkey
includ
turkey
similar
transcript
level
mrna
present
studi
demonstr
neutral
epitopecontain
tcov
fragment
encompass
carboxylterminu
aminoterminu
amino
acid
residu
fragment
induc
neutral
antibodi
provid
partial
protect
infecti
challeng
tcov
fulllength
protein
sarscov
shown
activ
cellmedi
immun
respons
induc
antibodi
product
block
viral
bind
fusion
infect
et
al
kam
et
al
conformationdepend
neutral
epitop
locat
subunit
ibv
kant
et
al
conformationindepend
neutral
epitop
found
amino
acid
carboxylterminu
amino
acid
aminoterminu
kuster
et
al
chicken
inocul
peptid
antigen
epitop
correspond
amino
acid
residu
ibv
produc
antibodi
provid
protect
ibv
infect
kidney
protect
trachea
ignjatov
sapat
expos
domain
subunit
sarscov
amino
acid
residu
induc
antibodi
product
inhibit
viral
infect
studi
suggest
fragment
coronaviru
contain
neutral
epitop
capabl
elicit
protect
antivir
antibodi
respons
dna
vaccin
gener
humor
cellular
immun
specif
protect
antigen
variou
pathogen
deliveri
dna
plasmid
cell
antigen
protein
endogen
produc
present
mhc
class
thu
induc
cytotox
tcell
respons
therefor
dna
vaccin
abil
mimic
effect
live
attenu
vaccin
without
revers
virul
due
recombin
mutat
live
attenu
pathogen
plasmid
easili
produc
bacteria
without
risk
improp
fold
instabl
express
recombin
protein
laddi
weiner
coban
et
al
primeboost
strategi
use
nanoparticl
aid
dna
deliveri
undertaken
enhanc
immunogen
protect
efficaci
dna
vaccin
present
studi
accord
woo
studi
woo
et
al
mice
prime
intramuscularli
dna
vaccin
boost
recombin
protein
produc
e
coli
shown
gener
highest
neutral
antibodi
titer
sarscov
infect
compar
dna
vaccin
protein
alon
hand
recombin
protein
express
e
coli
induc
high
igg
level
high
neutral
antibodi
titer
may
due
improp
conform
lack
glycosyl
recombin
protein
express
prokaryot
system
appear
conform
posttransl
modif
protein
express
dnatransfect
cell
adequ
induc
neutral
antibodi
thu
prime
dna
vaccin
overcom
issu
relat
conform
glycosyl
encount
vaccin
immun
recombin
protein
woo
et
al
addit
use
biodegrad
polymer
nanoparticl
one
potenti
mean
deliv
dna
combin
advantag
clpei
ha
dnaclpeiha
dph
system
significantli
higher
p
transfect
effici
polym
system
xu
et
al
primeboost
regimen
use
g
dna
dph
complex
first
dose
present
studi
provid
protect
regimen
use
g
dna
first
dose
dpi
turkey
vaccin
g
dna
dph
complex
show
local
tissu
respons
lesion
lower
ifa
score
viral
rna
load
ileum
turkey
receiv
g
dna
first
dose
howev
toxic
reveal
chicken
receiv
g
dna
dph
complex
subcutan
edema
hemorrhag
muscl
liver
observ
inocul
chicken
unpublish
data
although
applic
nanoparticl
clipei
ha
increas
transfect
effici
dna
vaccin
enhanc
protect
immun
respons
trigger
dna
vaccin
also
critic
use
appropri
dose
caus
toxic
tissu
chang
prior
challeng
stronger
tcovspecif
antibodi
respons
tcov
proteinbas
antibodycaptur
elisa
higher
neutral
antibodi
titer
efficaci
protect
infecti
challeng
tcov
seen
turkey
prime
two
dose
g
dna
vaccin
prime
one
dose
g
dna
vaccin
find
indic
frequenc
dna
vaccin
affect
kinet
magnitud
protect
antibodi
respons
studi
infecti
bursal
diseas
viru
ibdv
chicken
vaccin
one
dose
dna
vaccin
show
protect
day
viral
challeng
chicken
receiv
dose
dna
vaccin
show
protect
base
ibdvinduc
bursal
lesion
score
chang
et
al
addit
dna
encod
hemagglutinin
protein
influenza
viru
shown
increas
hemagglutininspecif
antibodi
product
doserespons
manner
singl
multipl
inject
dna
deck
et
al
robinson
et
al
therefor
protect
antibodi
respons
tcov
infect
enhanc
increas
dosag
andor
frequenc
dna
vaccin
mrna
level
turkey
determin
qrtpcr
use
evalu
cellmedi
immun
respons
vaccin
infecti
challeng
tcov
primarili
produc
activ
cytotox
cell
natur
killer
cell
signific
upregul
transcript
note
vaccin
present
studi
indic
tcov
fragment
contain
neutral
epitop
activ
involv
activ
stimul
cellmedi
immun
primarili
induc
strong
humor
immun
respons
tcov
downregul
level
result
reduc
number
natur
killer
cell
macrophag
activ
cell
activ
cell
frank
et
al
increas
number
cell
zheng
et
al
physic
strain
intramuscular
inject
may
result
stress
lead
immunosuppress
inhibit
product
greenfeld
et
al
addit
pei
may
caus
apoptosi
reduc
number
cell
even
though
pei
may
affect
type
immun
cell
fischer
et
al
therefor
reduc
elimin
stressinduc
immunosuppress
due
vaccin
import
factor
consid
induct
immun
dna
vaccin
protect
provid
vaccin
coronaviru
infect
involv
humor
andor
cellular
immun
respons
seo
et
al
marten
et
al
yang
et
al
thirion
couteli
vaccin
mice
protect
sarscov
infect
produc
high
level
igg
neutral
antibodi
signific
immun
respons
yang
et
al
woo
et
al
protect
mediat
humor
tcell
depend
immun
mechan
deplet
cell
use
specif
monoclon
antibodi
affect
vaccineinduc
immun
addit
adopt
tcell
transfer
show
donor
immun
cell
unabl
reduc
pulmonari
viral
replic
recipi
anim
passiv
transfer
purifi
igg
immun
mice
provid
immun
protect
yang
et
al
hand
adopt
transfer
ibv
prime
cell
bear
antigen
protect
chick
ibv
infect
passiv
transfer
convalesc
ibv
serum
protect
chicken
respiratori
infect
although
viral
replic
delay
kidney
diseas
prevent
macdonald
et
al
seo
et
al
studi
mous
hepat
viru
mhv
acut
infect
primarili
control
cell
cell
b
cell
nk
cell
contribut
reduc
viral
replic
marten
et
al
thirion
couteli
thu
humor
cellular
immun
provid
optim
protect
coronavir
infect
dna
vaccin
base
n
gene
provid
protect
tcov
infect
turkey
dna
vaccin
base
n
gene
alon
previou
studi
suggest
humor
cellular
immun
critic
protect
tcov
turkey
sinc
dna
vaccin
encod
n
protein
tcov
induc
cellular
immun
respons
antibodi
respons
ababneh
therefor
futur
studi
dna
vaccin
tcov
infect
includ
dna
vaccin
encod
neutral
epitop
protein
cell
epitop
n
protein
gener
adequ
humor
cellular
immun
respons
offer
optim
protect
tcov
infect
oral
administr
vaccin
suitabl
field
applic
oral
vaccin
stimul
protect
mucos
immun
respons
investig
oral
deliveri
tcov
dna
vaccin
fowl
adenoviru
johnson
et
al
attenu
salmonella
jiao
et
al
woo
et
al
biodegrad
nanoparticl
plapi
et
al
method
warrant
dnaprim
proteinboost
dna
vaccin
target
tcov
protein
fragment
contain
neutral
epitop
provid
partial
protect
tcov
infect
elicit
protect
humor
immun
respons
lessen
elimin
clinic
sign
reduc
viral
load
ileum
infect
turkey
